Overview

Camrelizumab and Chemotherapy Combined With Endoscopic Surgery for Recurrent Nasopharyngeal Carcinoma

Status:
Recruiting
Trial end date:
2025-08-10
Target enrollment:
Participant gender:
Summary
To explore the effect of Camrelizumab and chemotherapy combining with endoscopic surgery in the treatment of recurrent nasopharyngeal carcinoma.
Phase:
Phase 2
Details
Lead Sponsor:
Eye & ENT Hospital of Fudan University
Collaborator:
Chinese Academy of Medical Sciences